Companies

iOrganBio

iorganbio.com

AI-powered manufacturing platform for the precision engineering of human cells and organoids.

Employees11-50
Funding$2M
Healthcare AIAI ApplicationB2B SaaSSeed$1M-$10M

About

iOrganBio provides an AI-powered manufacturing platform called CellForge for the precision engineering of human cells and organoids. Targeting biopharma partners, the company enables scalable and reproducible outcomes for in vitro modeling, drug discovery, and cell therapies. They monetize through a B2B model, leveraging a proprietary Functional Human CellAtlas for digital blueprints of cell types.

Active Roles

0

No active roles right now.

Get notified when they post

Key Investors

First Star Ventures, IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, Alix Ventures, SOSV